A stronger foundation for AI in toxicology.
Curated reference data and reproducible workflows for MicroCT segmentation.
Explore Merck’s story ↗Clinical validation, revalidation and post-market monitoring—across teams, products and versions.
Managed by our experts. Connected by our platform.
CB Insights AI 100 2024 selection ↗Our platform, data and clinical expert services supported the evidence behind FDA clearances for Computer Vision and Prenuvo. Explore those milestones alongside Merck’s preclinical research.
Curated reference data and reproducible workflows for MicroCT segmentation.
Explore Merck’s story ↗
Clinical evidence for lumbar-spine AI. A continuing relationship across updates and new products.
Explore the relationship ↗Expert validation supporting clearance for an AI product now offered in clinical care.
Explore Prenuvo’s story ↗Source, license and curate through clinical partnerships.
Register models and run inference on the study cohort.
Coordinate physician annotation, review and adjudication.
Run the agreed protocol against the expert reference.
Trace results to the data, model version and protocol.
Keep clinical, data science, RA/QA and product teams connected to the same version-specific evidence.
See how the work connects ↗Evidence for your intended clinical use.
Execute the initial study ↗Evaluate changes as products evolve.
Evaluate the next version ↗Monitor live performance. Investigate and act.
Monitor performance ↗Governance carries through every stage. Explore change evaluation under an FDA-authorized PCCP, where applicable ↗
Market intelligence on regulation, research, adoption and the companies shaping healthcare AI. Clear sources. Actionable context for your next product and regulatory decision.
Explore Gesund Signal →Latest · From Lag to Live: The FDA's Real-Time Clinical Trial Initiative and What It Means for Health AI
Start with your product, timeline and clinical evidence question.